academic article

• Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria..  Cardiovascular drugs and therapy.  33:189-199. 2019
• Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study)..  The American journal of cardiology.  122:768-774. 2018
• PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)..  Circulation.  137:1260-1269. 2017